Advertisement

Topics

Novartis seeks first-line use for lung cancer drug Zykadia

07:56 EDT 23 Sep 2016 | PMLIVE

Looks to go head-to-head with Pfizer/Merck KGaA’s Xalkori and Roche’s Alecensa

Original Article: Novartis seeks first-line use for lung cancer drug Zykadia

NEXT ARTICLE

More From BioPortfolio on "Novartis seeks first-line use for lung cancer drug Zykadia"

Quick Search
Advertisement
 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...